期刊
CLINICAL AND EXPERIMENTAL IMMUNOLOGY
卷 167, 期 1, 页码 15-25出版社
WILEY
DOI: 10.1111/j.1365-2249.2011.04469.x
关键词
B cell; haematopoietic stem cell transplantation; lymphocyte development
类别
资金
- Swedish Children's Cancer Foundation
- Sahlgrenska University Hospital Foundation
- Swedish Research Council
- Mucosal Immunobiology and Vaccine Centre (MIVAC)
Haematopoietic stem cell transplantation (HSCT) is an immunological treatment that has been used for more than 40 years to cure a variety of diseases. The procedure is associated with serious side effects, due to the severe impairment of the immune system induced by the treatment. After a conditioning regimen with high-dose chemotherapy, sometimes in combination with total body irradiation, haematopoietic stem cells are transferred from a donor, allowing a donor-derived blood system to form. Here, we discuss the current knowledge of humoral problems and B cell development after HSCT, and relate these to the current understanding of human peripheral B cell development. We describe how these studies have aided the identification of subsets of transitional B cells and also a robust memory B cell phenotype.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据